EUVIMEDEUVIMED entdecken
Crossref

A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy

Mengyu Chang, Man Wang iD, Bin Liu, Wenbin Zhong, Deblin Jana, Yifan Wang, Shiyan Dong, Abin Antony, Chunxia Li iD, Yuhui Liu, Zhongqi Zhao, Jun Lin iD und 2 weitere

ACS Nano · 2024

DOI: 10.1021/acsnano.3c11960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Mengyu Chang und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, 637371, Singapore. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms, Artemisinins. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Research Foundation Singapore, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsArtemisininsHumansReactive Oxygen SpeciesNanovaccinesAluminumIronHydroxidesImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

augmented reactive oxygen speciescancer nanovaccinedihydroartemisininlayered double hydroxidesmetalloimmunotherapy

Substanzen

Reactive Oxygen SpeciesNanovaccinesAluminumartenimolIronHydroxidesArtemisinins

Autor:innen und Institutionen

  • School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, 637371, Singapore.
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
  • State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China.
  • Institute of Molecular Sciences and Engineering, Shandong University, Qingdao 266237, P. R. China.
  • State Key Laboratory of Nuclear Resources and Environment, East China University of Technology, Nanchang 330013, P. R. China.
  • Department of Electrical and Computer Engineering, University of Houston, Houston, Texas 77004, United States.

ORCID-Profile: Man Wang, Chunxia Li, Jun Lin, Wen Jiang, Yanli Zhao

Förderung

  • National Research Foundation Singapore
  • National Natural Science Foundation of China

Zitieren

APA

Chang, M., Wang, M., Liu, B., Zhong, W., Jana, D., Wang, Y., Dong, S., Antony, A., Li, C., Liu, Y., Zhao, Z., Lin, J., Jiang, W., & Zhao, Y. (2024). A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.3c11960

Vancouver

Chang M, Wang M, Liu B, Zhong W, Jana D, Wang Y, et al. A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy. ACS Nano. 2024. doi:10.1021/acsnano.3c11960

BibTeX
@article{Chang2024,
  author = {Chang, Mengyu and Wang, Man and Liu, Bin and Zhong, Wenbin and Jana, Deblin and Wang, Yifan and Dong, Shiyan and Antony, Abin and Li, Chunxia and Liu, Yuhui and Zhao, Zhongqi and Lin, Jun and Jiang, Wen and Zhao, Yanli},
  title = {A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.3c11960}
}
Kostenlos starten →